Learn more

STELIC INSTITUTE REGENERATIVE MEDICINE

Overview
  • Total Patents
    39
About

STELIC INSTITUTE REGENERATIVE MEDICINE has a total of 39 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COGNOSCI INC, GALPHARMA CO LTD and CELL SIGNALS INC.

Patent filings per year

Chart showing STELIC INSTITUTE REGENERATIVE MEDICINEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yoneyama Hiroyuki 39
#2 Koyama Jun 12
#3 Fujii Masato 8
#4 Ichida Takafumi 5
#5 Wakamatsu Kyoko 4
#6 Narumi Shosaku 4
#7 Ishida Kenji 4
#8 Narimi Shosaku 2
#9 Takeya Motohiro 2
#10 Tagashira Hideki 2

Latest patents

Publication Filing date Title
JP2013000174A Image processing apparatus, image processing method, and image processing program
WO2009084232A1 Sugar chain-related gene and use thereof
JP2009108033A Hepatic fibrosis-suppressing agent
WO2008149980A1 Fibrosis inhibitor
JP2009178143A Steatohepatitis-liver cancer model animal
JP2009180711A Bio-marker
JP2008094856A Agent for promoting hepatocyte replication and agent for improving insulin resistance
WO2008029871A1 Nerve fiber degeneration inhibitor
EP2022846A1 Method for isolation of stem cell
WO2008023446A1 Remedy for chronic obstructive pulmonary disease
WO2008020489A1 Remedy for inflammatory bowel disease
US2009202515A1 Agents for suppressing neural fibrotic degeneration
JP2010013355A Myocardial injury-controlling agent
US2009060892A1 Agents for suppressing hepatic fibrosis
JP2009286695A Ocular fibrous neovascularization inhibitor
JP2009292725A Kidney disease-improving agent
JP2009234916A Insulin resistance reducer based on chondroitin sulfate proteoglycan accumulation regulation
US2009081787A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance